Search

Abstract This work deals with the preparation of freeze-cast scaffolds using sol-gel derived 58S bioactive glass and a hypoeutectic naphthalene-camphor mixture as the starting powder and freezing vehicle, respectively. After the freeze-casting step, samples were air sintered at 1250 °C for 2 h, which led to the crystallization of 58S. The obtained scaffolds were subsequently infiltrated with poly(ε-caprolactone) (PCL), a biodegradable polymer with potential application for bone tissue repair. The prepared materials were examined by helium pycnometry, laser granulometry, scanning electron microscopy (SEM), Archimedes tests, X-ray microtomography (micro-CT), Fourier transform infrared spectroscopy (FTIR), N 2 adsorption, X-ray diffraction (XRD), and uniaxial compression tests. Samples cytotoxicity was evaluated by (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) tetrazolium reduction (MTT) and LIVE/DEAD assays. Their biocompatibility was also examined after soaking in a simulated body fluid (SBF) solution at 37 °C for up to 14 days. It was observed that the infiltration of PCL into the 58S scaffolds greatly increased their mechanical stability. Moreover, it was shown that these composites displayed a high cell viability (above 70%), which reveals that they did not interfere in the production of osteoblast cells. A hydroxyapatite coating was observed on the samples surface upon soaking in SBF, reinforcing that they are biocompatible materials. As far as we know, this is the first time that freeze-cast scaffolds were obtained using sol-gel derived 58S particles and a naphthalene-camphor mixture. Besides, as the infiltration of PCL into freeze-cast bioactive glass scaffolds improved their mechanical stability without impairing their bioactivity, this is a promising approach to prepare samples for load-bearing applications in bone tissue engineering. [ABSTRACT FROM AUTHOR]

Nanobiomaterials can be engineered to recognize cancer-specific receptors at the cellular level for diagnostic and therapeutic purposes. In this work, we report the synthesis of novel multifunctional nanoconjugates composed of fluorescent inorganic semiconductor quantum dot (QD) cores and tripeptide-modified polysaccharide organic shells. These structures were designed for targeting and imaging the α v β 3 integrin receptors of cancer cells. Initially, chitosan was covalently bound with the RGD peptide using a crosslinker to form bioconjugates (RGD-chitosan), which were later utilized as capping ligands for the production of surface-functionalized CdS QDs via a single-step process in aqueous media at room temperature. These core-shell nanostructures were extensively characterized by UV–vis spectroscopy, photoluminescence (PL) spectroscopy, Fourier transform infrared spectroscopy (FTIR), transmission electron microscopy (TEM), zeta potential (ZP) and dynamic light scattering (DLS). The TEM images and the UV–vis absorption results indicated the formation of ultra-small CdS QD nanocrystals with average diameters between 2.0 and 3.0 nm. In addition, the PL results demonstrated that the nanobioconjugates exhibited intense green fluorescence under excitation. The CdS-RGD-chitosan systems were effective at specific targeting integrin when assayed in vitro using two model cell cultures, HEK 293 (non-cancerous human embryonic kidney cell) and SAOS (cancerous sarcoma osteogenic-derived cells) imaged using fluorescence microscopy. [ABSTRACT FROM AUTHOR]

Cancer remains one of the world's most devastating diseases with millions of fatalities and new cases every year. In this work, we attempted to develop a facile “enzyme-free” fluoroimmunoassay based on the novel nanoconjugates composed of CdS quantum dots (QDs) as the fluorescent inorganic core and an antibody-modified polysaccharide as the organic shell, modeling their possible application for the in vitro diagnosis of non-Hodgkin lymphoma (NHL) cancer. Chitosan was conjugated with an anti-CD20 polyclonal antibody (pAbCD20) by the formation of covalent amide bonds. In the sequence, these chitosan-antibody conjugates were utilized as direct ligands for the surface biofunctionalization of CdS QDs (CdS/chitosan-pAbCD20) using a single-step colloidal process in aqueous medium at room temperature. The most relevant physico-chemical properties of these nanoconjugates were assessed by morphological and spectroscopic techniques. The results indicated that CdS nanocrystals were produced with an average diameter of 2.5 nm and with cubic zinc blende crystalline nanostructure. The CdS-immunoconjugates (CdS/chitosan-pAbCD20) presented colloidal hydrodynamic diameter (H D ) of 15.0 ± 1.2 nm. In addition, the results evidenced that the “enzyme-free” QD-linked immunosorbent assay (QLISA) was effective for the in vitro detection against the antigen CD20 (aCD20) based on fluorescent behavior of the CdS nanoconjugates. Moreover, the CdS-immunoconjugates were successfully used for fluorescence bioimaging of NHL cancer cells. Finally, the cell viability results using different cell cultures based on LDH, MTT and Resazurin bio-assays have demonstrated no cytotoxicity of the new CdS-chitosan bioconjugates relative to the standard controls. Thus, CdS conjugates may offer a promising platform for the future development of in vitro and in vivo applications for the detection and diagnosis of NHL cancer cells. [ABSTRACT FROM AUTHOR]